- Home
- WNC vs TERN Comparison
WNC vs TERN Comparison
Compare WNC & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WNC
- TERN
- Stock Information
- Founded
- WNC 1985
- TERN 2017
- Country
- WNC United States
- TERN United States
- Employees
- WNC N/A
- TERN N/A
- Industry
- WNC Construction/Ag Equipment/Trucks
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- WNC Industrials
- TERN Health Care
- Exchange
- WNC Nasdaq
- TERN Nasdaq
- Market Cap
- WNC 454.7M
- TERN 495.2M
- IPO Year
- WNC 1991
- TERN 2021
- Fundamental
- Price
- WNC $10.64
- TERN $6.96
- Analyst Decision
- WNC Hold
- TERN Buy
- Analyst Count
- WNC 1
- TERN 5
- Target Price
- WNC $9.50
- TERN $15.63
- AVG Volume (30 Days)
- WNC 960.2K
- TERN 1.0M
- Earning Date
- WNC 07-25-2025
- TERN 08-05-2025
- Dividend Yield
- WNC 2.96%
- TERN N/A
- EPS Growth
- WNC N/A
- TERN N/A
- EPS
- WNC N/A
- TERN N/A
- Revenue
- WNC $1,720,560,000.00
- TERN N/A
- Revenue This Year
- WNC N/A
- TERN N/A
- Revenue Next Year
- WNC $18.05
- TERN N/A
- P/E Ratio
- WNC N/A
- TERN N/A
- Revenue Growth
- WNC N/A
- TERN N/A
- 52 Week Low
- WNC $6.78
- TERN $1.87
- 52 Week High
- WNC $20.63
- TERN $11.40
- Technical
- Relative Strength Index (RSI)
- WNC 56.03
- TERN 71.76
- Support Level
- WNC $10.47
- TERN $6.43
- Resistance Level
- WNC $11.11
- TERN $6.34
- Average True Range (ATR)
- WNC 0.44
- TERN 0.42
- MACD
- WNC 0.10
- TERN 0.04
- Stochastic Oscillator
- WNC 77.64
- TERN 98.68
About WNC Wabash National Corporation
Wabash National Corp operates as the innovation leader of connected solutions for the transportation, logistics, and distribution industries. The Company manages its business in two operating and reportable segments: Transportation Solutions and Parts & Services. It designs and manufactures products including dry freight and refrigerated trailers, platform trailers, tank trailers, dry and refrigerated truck bodies, structural composite panels and products, trailer aerodynamic solutions, and specialty food-grade processing equipment.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.